Does UBLITUXIMAB Cause Inappropriate schedule of product administration? 53 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 53 reports of Inappropriate schedule of product administration have been filed in association with UBLITUXIMAB (BRIUMVI). This represents 3.4% of all adverse event reports for UBLITUXIMAB.
53
Reports of Inappropriate schedule of product administration with UBLITUXIMAB
3.4%
of all UBLITUXIMAB reports
1
Deaths
0
Hospitalizations
How Dangerous Is Inappropriate schedule of product administration From UBLITUXIMAB?
Of the 53 reports, 1 (1.9%) resulted in death.
Is Inappropriate schedule of product administration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UBLITUXIMAB. However, 53 reports have been filed with the FAERS database.
What Other Side Effects Does UBLITUXIMAB Cause?
Infusion related reaction (538)
Fatigue (110)
Headache (55)
Malaise (49)
Multiple sclerosis relapse (48)
Asthenia (45)
Pain (45)
Illness (43)
Urinary tract infection (42)
Covid-19 (39)
What Other Drugs Cause Inappropriate schedule of product administration?
ADAPALENE (16,473)
DUPILUMAB (14,927)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (12,546)
INSULIN GLARGINE (8,982)
INFLIXIMAB (6,847)
INFLIXIMAB-DYYB (5,977)
SECUKINUMAB (4,817)
DULAGLUTIDE (3,606)
VEDOLIZUMAB (3,259)
SACUBITRIL\VALSARTAN (2,870)
Which UBLITUXIMAB Alternatives Have Lower Inappropriate schedule of product administration Risk?
UBLITUXIMAB vs UBLITUXIMAB-XIIY
UBLITUXIMAB vs UBROGEPANT
UBLITUXIMAB vs ULIPRISTAL
UBLITUXIMAB vs UMBRALISIB
UBLITUXIMAB vs UMECLIDINIUM